Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.

Wang WL, Patel NR, Caragea M, Hogendoorn PC, López-Terrada D, Hornick JL, Lazar AJ.

Mod Pathol. 2012 Oct;25(10):1378-83. doi: 10.1038/modpathol.2012.97. Epub 2012 Jul 6.

2.

ERG and FLI1 protein expression in epithelioid sarcoma.

Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL.

Mod Pathol. 2014 Apr;27(4):496-501. doi: 10.1038/modpathol.2013.161. Epub 2013 Sep 27.

3.

Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.

Specht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR.

Genes Chromosomes Cancer. 2014 Jul;53(7):622-33. doi: 10.1002/gcc.22172. Epub 2014 Apr 10.

4.

Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.

Rekhi B, Vogel U, Basak R, Desai SB, Jambhekar NA.

Pathol Oncol Res. 2014 Jul;20(3):503-16. doi: 10.1007/s12253-013-9721-2. Epub 2013 Nov 30.

PMID:
24293381
5.

Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.

Tomlins SA, Palanisamy N, Brenner JC, Stall JN, Siddiqui J, Thomas DG, Lucas DR, Chinnaiyan AM, Kunju LP.

Am J Clin Pathol. 2013 Jun;139(6):771-9. doi: 10.1309/AJCPN4L1BMRQPEIT.

6.

Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.

Warren M, Weindel M, Ringrose J, Venable C, Reyes A, Terashima K, Rao P, Chintagumpala M, Hicks MJ, Lopez-Terrada D, Lu XY.

Hum Pathol. 2013 Oct;44(10):2010-9. doi: 10.1016/j.humpath.2013.03.003. Epub 2013 May 22.

PMID:
23706910
7.

Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.

Camões MJ, Paulo P, Ribeiro FR, Barros-Silva JD, Almeida M, Costa VL, Cerveira N, Skotheim RI, Lothe RA, Henrique R, Jerónimo C, Teixeira MR.

PLoS One. 2012;7(11):e49819. doi: 10.1371/journal.pone.0049819. Epub 2012 Nov 19.

8.

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.

de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindán FJ, Barr FG, Ladanyi M.

Am J Pathol. 2000 Mar;156(3):849-55.

9.

Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.

Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali PG, Perrone F, Tamborini E, Pellegrinelli A, Gherardi G, Arrigoni G, Collini P, Testi A, De Paoli E, Aiello A, Pilotti S, Pelosi G.

Histopathology. 2014 Jun;64(7):1014-26. doi: 10.1111/his.12350. Epub 2014 Feb 25.

PMID:
24898918
10.

Utilisation of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues.

Patócs B, Németh K, Garami M, Arató G, Kovalszky I, Szendroi M, Fekete G.

J Clin Pathol. 2012 Dec;65(12):1112-8. doi: 10.1136/jclinpath-2012-201154. Epub 2012 Sep 26.

PMID:
23015660
11.

Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.

Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ.

Nat Genet. 1999 Oct;23(2):222-7. Erratum in: Nat Genet 1999 Dec;23(4):481.

PMID:
10508522
12.

The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.

Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke HJ, Hogendoorn PC.

Clin Cancer Res. 2009 Apr 1;15(7):2259-68. doi: 10.1158/1078-0432.CCR-08-2184. Epub 2009 Mar 24.

13.

EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.

Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ.

Cancer Res. 2000 Mar 15;60(6):1536-40.

14.

Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.

Patócs B, Németh K, Garami M, Arató G, Kovalszky I, Szendrői M, Fekete G.

Cell Oncol (Dordr). 2013 Jun;36(3):191-200. doi: 10.1007/s13402-013-0126-8. Epub 2013 Mar 14.

PMID:
23494411
15.

Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.

Arnold MA, Ballester LY, Pack SD, Abdullaev Z, Merchant M, Tsokos MG.

Pediatr Dev Pathol. 2014 Jul-Aug;17(4):302-7. doi: 10.2350/14-03-1454-CR.1. Epub 2014 Apr 15.

PMID:
24735198
16.

Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.

Sadri N, Barroeta J, Pack SD, Abdullaev Z, Chatterjee B, Puthiyaveettil R, Brooks JS, Barr FG, Zhang PJ.

Virchows Arch. 2014 Aug;465(2):233-9. doi: 10.1007/s00428-014-1613-7. Epub 2014 Jul 4.

PMID:
24993903
17.

Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.

Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, Takizawa T, Nakamura T.

Hum Mol Genet. 2006 Jul 1;15(13):2125-37. Epub 2006 May 22.

18.

Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.

Bilke S, Schwentner R, Yang F, Kauer M, Jug G, Walker RL, Davis S, Zhu YJ, Pineda M, Meltzer PS, Kovar H.

Genome Res. 2013 Nov;23(11):1797-809. doi: 10.1101/gr.151340.112. Epub 2013 Aug 12.

19.

STAT3 is activated in a subset of the Ewing sarcoma family of tumours.

Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD.

J Pathol. 2006 Apr;208(5):624-32.

PMID:
16463269
20.

MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.

Franzetti GA, Laud-Duval K, Bellanger D, Stern MH, Sastre-Garau X, Delattre O.

Oncogene. 2013 Aug 15;32(33):3915-21.

PMID:
22986530
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk